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Formalin fixation and paraffin embedding (FFPE) represent the standard method to
preserve tissue specimens for diagnostic pathology, however formalin fixation induces
severe fragmentation of nucleic acids. We investigated whether formalin fixation at 4◦C
could preserve DNA integrity in FFPE specimens. Paired samples from 38 specimens
were formalin fixed at room temperature (stdFFPE) and at 4◦C (coldFFPE), respectively.
Two independent cohorts were prospectively collected, cohort A (collected 6 years prior
to the study, n= 21), cohort B (collected at time of the study, n= 17). DNA was extracted
and its integrity evaluated with a qPCR-based assay that produces a normalized integrity
index, the QC score (ratio between the quantity of a long and a short amplicon of the
same gene). We observed higher QC scores in coldFFPE compared to stdFFPE samples
(mean values: 0.69 vs. 0.36, p< 0.0001) and stdFFPE breast cancer specimens showed
the most detrimental effect overall. Comparable QC scores were obtained between
coldFFPE tissues of both cohorts; conversely, DNA integrity of stdFFPE was significantly
lower in cohort A compared to cohort B (p < 0.0001). Of note, QC scores of stdFFPE
(but not of coldFFPE) samples were significantly reduced following 6months of storage (p
= 0.0001). Monitored formalin fixation at 4◦C outperforms standard fixation in ensuring
high-quality DNA, which is key to feasibility of downstream high-throughput molecular
analyses. An important effect was observed over storage time, thus suggesting a likely
better preservation of archival samples when this cold fixation protocol is used.
Keywords: fixation, cold formalin, DNA fragmentation, molecular diagnostics, breast cancer, diagnostic accuracy,
oncology, biomarkers
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INTRODUCTION
The harmonization of pre-analytic procedures represents the
corner stone of optimal diagnosis in pathology (1, 2). The
preanalytical phase in pathology includes different steps,
spanning from transportation of tissue specimens from surgical
theaters to pathology laboratories, grossing, and fixation of
tissues (type of fixative and duration of fixation are key
features in this respect). Tissue fixation in formalin with
generation of formalin-fixed paraffin embedded (FFPE) tissues
blocks represents the standard method for tissue specimen
processing and archival in diagnostic pathology at present. Of
note, heterogeneous tissue handling methods typically lead to
inefficiency and poor reproducibility in pathology laboratories.
Tissue fixation in formalin, with the generation of formalin-fixed
paraffin embedded (FFPE) tissue blocks, represents the standard
method for tissue specimen processing and archival in diagnostic
pathology. With the tremendous advances of precision medicine
pathologists face the challenge to integrate morphology and
immunophenotyping with genetic and epigenetic analyses, which
require purification of good quality nucleic acids from FFPE
blocks. In addition, FFPE tissue blocks preserved in pathology
archives may constitute the substrate for comprehensive “omics”
strategies, in the context of both prospective and retrospective
experimental studies.
It is widely accepted that formalin fixation exerts a blasting
effect on both DNA and RNA, with damages comprising
fragmentation, non-canonical cross-linkage and base alterations,
with critical proportional consequences related with storage time
(3, 4). Of note, Polymerase-Chain Reaction (PCR)-based next
generation sequencing (NGS) methods are strongly influenced
by formalin artifacts, reducing the library performance. The
extensive fragmentation of DNA purified from FFPE samples
usually leads to lower coverage of unique reads in whole genome
and whole exome sequencing approaches (5), but it may also
decrease the success rate of amplicon-based methods due to
reduced size of DNA templates (6). Moreover, the low quality of
DNA from FFPE samples also stems from formalin induced base
artifacts within the sequences, generating false mutation calls, in
particular in sub-clonal experiments (7).
We have previously reported on a protocol, i.e., cold formalin
fixation, which improves RNA quality without interfering with
the formalin ability to preserve both tissue structure and
antigen reliability for immunohistochemical analyses (2). This
modified formalin fixation may represent an easy alternative to
conventional formalin fixation ensuring a better preservation of
analytes. In addition, a standard method is needed to identify
those DNA samples reaching the minimal parameter to obtain
robust results. For the large majority of genomic downstream
applications, the assessment of DNA size distribution, the ratio
between long and short fragments as well as the amplifiability of
samples can contribute as parameters to define a quality score (8).
Based on these premises, the aim of our study was to
comprehensively characterize a series of DNA samples purified
from tissues derived from the same surgical resection but
processed with two different fixation protocols (standard fixation
vs. cold fixation at 4◦C), and to assess whether results would differ
based on the tissue of origin. Fluorometric, spectrophotometric
and qPCR-based methods were applied to assess DNA integrity.
MATERIALS AND METHODS
Sample Collection and Sampling
Procedures
The 38 paired samples included in the study were ad hoc
collected from surgical specimens handled by under-vacuum
packing and cooling (VPAC), as previously described (2, 9,
10). All of the surgical specimens enrolled in this study
were at least 2 cm in size to allow for proper parallel
sampling of comparable size and thickness. Informed consent
was obtained from all individual participants included in the
study (protocol “Profiling” 001-IRCC-00IIS-10, approved by the
Ethical Committee of Fondazione Piemontese per l’Oncologia-
Istituto di Ricerca e Cura a Carattere Scientifico of Candiolo).
All experimental procedures were performed in accordance with
relevant guidelines and regulations. It should be noted, however,
that the sampling did not affect the diagnostic process as the
adopted procedure did not require additional samplings, rather
included a variation of tissue processing for parallel samples,
already validated in a previous study as non-interfering with
morphological evaluation (2). Of note, all of the tissue samples
were available to the pathologist in charge of signing out the
final diagnosis. Each tumoral lesion was sampled in parallel
as follows: (i) standard fixation procedure (stdFPPE): samples
were fixed for 24 h in 4% neutral-buffered formalin (NBF) at
room temperature (RT). Subsequently, samples were processed
to paraffin embedding with an automatic tissue processor and
embedded in paraffinwax; (ii) cold fixation procedure (coldFFPE):
the sample was immersed in pre-cooled 4% NBF and fixed at
4◦C for 24 h. For this protocol, specimens were dehydrated in
ethanol 95% at 4◦C for 4 h and then followed the same stdFFPE
sample processing without the first ethanol 95% step by using the
automated tissue processor. All of the methods were performed
in accordance with the relevant guidelines and regulations.
Out of the 38 cases, 21 pairs were collected and fixed 6
years prior to the present study (Cohort A, collected between
2012 and 2013) and 17 samples prospectively collected at
time of the present study (Cohort B, collected in early 2019)
(Figure 1). Cohort A included 11 breast carcinomas of no
special type, three colorectal adenocarcinomas, three cases of
lung adenocarcinoma, two gastric adenocarcinomas, and two
thyroid follicular carcinomas (Supplementary Table 1). Cohort
B was composed of eight cases of colorectal adenocarcinoma,
two Gastro-Intestinal Stromal Tumors (GISTs), two lung
adenocarcinomas, one intrahepatic cholangiocarcinoma, one
splenic metastasis of endometrial carcinoma, one high grade
serous-papillary ovarian carcinoma, one case of pleomorphic
undifferentiated sarcoma and one adenocarcinoma of the
gallbladder (Supplementary Table 1).
Nucleic Acid Extraction and Quantification
A pathologist evaluated histological and pathological
features of the cases included in both cohorts and the
tumor area was identified on the hematoxylin and eosin
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FIGURE 1 | Design of the study. The full cohort comprised 38 cancer
specimens that were collected and sampled in parallel to allow standard
fixation (i.e., at room temperature) and cold formalin fixation (i.e., at 4◦C).
Following processing and tissue sectioning the H&E slides were reviewed to
identify the tumor area that was mesodissected for DNA extraction. Two
independent cohorts were prospectively collected: Cohort A, whose sampled
were collected 6 years prior to the study and DNA extraction performed at
present time; Cohort B, whose samples were collected at time of the present
study with contextual DNA extraction. For 14 samples from Cohort B, i.e.,
corresponding to those samples for which at least 6 months elapsed from
collection, two DNA extractions were performed: at baseline (at time of
collection/fixation) and after 6 months of storage/archival. On the total 90 DNA
samples we performed fluorometric and spectrophotometric quantifications
and we ran a qPCR with the DEPArrayTM FFPE QC Kit. RT, room temperature;
NBF, neutral buffered formalin; EtOH, ethanol.
(H&E) stained slide before proceeding to the experimental
procedure for both stdFFPE and coldFFPE samples. Data
were analyzed anonymously. Five 8-µm thick sections were
dissected and DNA samples were purified from all the 38
FFPE pairs for a total of 72 DNA samples. In addition,
in 14 cases from cohort B for which at least 6 months
elapsed from collection paired stdFFPE and coldFFPE
samples underwent a second DNA extraction 6 months
after collection/fixation.
DNA was extracted using the QIAamp DNA FFPE Tissue
Kit (Qiagen, Hilden, Germany) according to the manufacturer’s
protocol, following an overnight 56◦C tissues lyses allowing
a complete tissue digestion without fragmenting the DNA.
DNA was eluted in 40µL of nuclease-free water and quantified
using the Qubit 3.0 Fluorimeter (Life Technologies, Wilmington,
DE, USA) following the protocol of High Sensitivity DNA
Kit (Life Technologies, Eugene, OR, USA). To check for
any possible contaminant on the purified samples, DNA
concentration was also evaluated using the DeNovix DS-11 UV-
Vis Spectrophotometer (DeNovix, Wilmington, DL, USA) to
obtain the 260/230 and the 260/280 nm ratios.
DNA Fragmentation Analyses
DNA fragmentation was evaluated by using the DEPArrayTM
FFPE QC Kit (Menarini-Silicon Biosystem, Bologna, Italy). This
qPCR-based kit is a multiplex reaction composed of two primers
pairs flanking two regions of 54 and 132 bp of the same genomic
locus. To quantify the amount of the produced amplicons, a
standard curve for each primer pair was generated. To infer the
DNA integrity level, the ratio between the quantity of the long
amplicon (e.g., most conserved DNA) and the short amplicon is
calculated. This ratio, named QC score, is a normalized number
tending either to 1, in a context of highly conserved DNA, or to
0, in a scenario of diffuse DNA degradation.
Briefly, the standard curve points were produced with serial
1:10 dilutions from an undiluted standard with a known
concentration of 20,000 pg/µL. To perform the assay, 8µL of
DNA with a concentration of 2 ng/ µL were added in two mix
composed by 10µL of the Master Mix and 2µL of the Short
or Long Primer mix for a final volume of 20µL. The thermal
cycle was run on a RotorGene Q instrument (Qiagen) and
contemplated an initial step of DNA denaturation for 10min
at 95◦C followed by 40 cycles of 20 s at 95◦C denaturation and
1min at 57.5◦C annealing/extension with the detection of FAM
fluorescence signal at 520 nM. To obtain optimal results, slope
and R2 parameters of the standard curve may be between 3.1 and
3.6 and 0.99, respectively. The fluorescence unit threshold was set
at 0.04 for all the experiment.
All samples and standards were analyzed with technical
triplicates in each experiment. The amount of amplified DNA
was checked analyzing the quantity of the short and long
amplicons assay products. By comparing the average Ct of
the three replicates with the standard curve the relative
quantification (RQ) of PCR product was obtained using the
formula 10(CTsample-INTERCETstdcurve/SLOPEstdcurve) for both the
short and long amplicon. The QC score was obtained by dividing
the long amplicon RQ by the short amplicon RQ.
Statistical Analyses
Statistical analyses were carried out using GraphPad Prism
statistical software v8.0 (GraphPad Software, La Jolla
California USA). After normality test, we applied both the
unpaired and paired distribution test to evaluate significant
differences in QC scores between the two-fixation methods.
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The unpaired distribution test was used to assess differences
by considering the QC scores as independent measurement
of uncorrelated samples, whereas the paired distribution
test evaluated the statistical distribution considering the
different fixation of the same sample as repeated and
correlated data. The Pearson’s correlation coefficient test
(r) was used to determine the correlation between QC scores of
corresponding stdFFPE and coldFFPE samples to determine any
intra-specimen influences.
We first analyzed the total cohort by merging the data
obtained from the two sets and then by separately considering
cohort A and cohort B. p-values of <0.05, with 95% confidence
intervals (CI), were considered as statistically significant.
RESULTS
Cases and Tissue Morphology
The H&E sections of corresponding stdFPPE and coldFFPE
samples were evaluated by pathologists blinded to the
experimental procedures of fixation. Only tumor cell areas
were selected for dissection and DNA purification. Tumor
cell composition was comparable between corresponding
samples for each case; minor differences were observed in
terms of relative percentage of immune cells populating
the intertumoral stroma. Necrotic areas were carefully
avoided through mesodissection. Only two sample pairs
were characterized by large necrotic areas interspersed among
tumor cell clusters and most likely contained a non-negligible
degree of necrosis in the extracted material, nevertheless no
evident technical-derived alterations were detected. Of note,
the pathologists involved in the assessment of morphological
features did not raise observations on fixation artifacts in any of
the samples.
DNA Quantity and Absorbance Quality
To determine any influence of the different fixation protocol on
DNA quantity and quality, we both applied fluorometric
and spectrophotometric methods to evaluate the DNA
amount. DNA concentration and ratios are reported
in Supplementary Tables 1, 2.
From the standard fixed samples, we purified a mean level
of 4.2 (range: 0.2–15.6µg) and 16.2µg (1.9–57.7µg) of DNA
analyzed with Qubit or DeNovix instruments, respectively. No
significant differences (p = 0.2) were detected by comparing
these data with the DNA quantity obtained from coldFFPE
samples, which were slightly higher by the fluorometric
(mean: 4.9µg, range: 0.3–16.4µg) and spectrophotometric
measurement (mean: 20.37µg, range: 2.4–55.8µg).
When considering Cohort A only, a significantly higher DNA
quantity was detected for coldFFPE compared with stdFFPE
samples (mean values: 4.1 µg vs. 2.1 µg, p = 0.04) using the
Qubit fluorometer instrument, which was not appreciated in
Cohort B. For both fixation methods the nucleic acid yield
was significantly higher in Cohort B than in Cohort A (p
= 0.03 and p < 0.0001 for coldFFPE and stdFFPE samples,
respectively), however the difference was less evident when
comparing coldFFPE than stdFFPE specimens (40% of reduction
against 70%) (Figure 2A).
No correlation between DNA amount and type of tumors was
detected. Finally, the fixation protocol did not influence the DNA
quality, defined as the absorbance ratio between 230/260 and
260/280 nm, which resulted comparable between the pairs.
DNA Fragmentation Analysis
The qPCR-based DEPArrayTM FFPE QC Kit returned a QC
score for each sample, a normalized evaluation of DNA
amplifiability. From a technical standpoint, the mean R2
scores of the standard curves were 0.994 and 0.993 for
the short and the long amplicon, respectively, and the line
slopes were comprised in the optimal range defined by the
manufacturer’s protocol.
All DNA samples were successfully amplified, and a QC
score was generated. More in detail, the stdFFPE DNA samples
were characterized by mean QC score of 0.36 (range: 0.03–
0.86), which was significantly lower than the corresponding
value in coldFFPE samples (mean: 0.69, range: 0.34–1.05).
By comparing the QC score distributions of the two sets
of samples, both the paired and unpaired tests reached the
statistical significance (p < 0.0001) (Figure 2B). We wondered
whether the intrinsic fragmentation of the samples could have
influenced this difference. In this context, the Pearson correlation
test described an independent trend for the QC value for
the two different fixation methodologies in the same sample
(r = 0.45) (Figure 2C).
When samples were clustered according to the time of fixation
(Cohort A vs. Cohort B) we observed that the QC scores of
coldFFPE samples were substantially comparable between the
two cohorts, regardless of time of fixation (p= 0.79), whereas the
QC score of stdFFPE samples was significantly lower in Cohort
A compared to the more recent prospectively accrued samples of
Cohort B (p < 0.0001) (Figure 2D). Within Cohort A, stdFPFPE
samples harbored the highest level of DNA fragmentation overall,
with a mean QC level of 0.12 (range: 0.03–0.27), in contrast
with the corresponding coldFFPE samples that showed a 6-
fold increase in the QC average (mean QC: 0.63, range: 0.24–
1.02; p < 0.0001). On the other hand, the DNA purified
from the 17 paired samples of Cohort B displayed a relatively
better preservation in both stdFFPE and coldFFPE, nevertheless
coldFFPE samples still showed a statistically significantly higher
QC distribution (p = 0.0016 and 0.038, paired and unpaired
t-tests respectively, Figure 2D).
DNA Integrity and Site of Origin of the
Tumor
We checked any possible association between the site of
origin of the tumor and the DNA preservation efficiency
of the two processing methods. The heterogeneity of our
population allowed to reach enough numerosity to obtain
statistically informative results only for breast, colorectal, and
lung carcinomas. We observed that the DNA purified from
breast carcinomas showed higher degrees of fragmentation
compared to colorectal and lung adenocarcinomas (Figure 3).
We obtained the lowest QC scores from stdFFPE breast
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FIGURE 2 | Quantity and quality of DNA extracted from parallel samples. (A) DNA quantification of samples. Violin plots representing the DNA µg purified from the
specimens, grouped according to the fixation methods (stdFFPE and coldFFPE) and the time of cohort collection [Cohort A (collected 6 years prior to the study with
DNA extraction at present time); Cohort B (collected at time of the present study with contextual DNA extraction)]. Cohort A was characterized by higher DNA yields
for coldFFPE compared to stdFFPE samples (4.1µg vs. 2.1µg, p = 0.04). As for Cohort B, violin plots showed a median-around density distribution for both stdFFPE
and coldFFPE samples that was significantly higher compared the same fixation protocol of Cohort A (p = 0.03 for cold fixation and p =0.0001 for standard fixation).
(B) Violin plots representing the QC score distribution in the groups clustered according to fixation method. The stdFFPE cohort was characterized by heterogeneous
QC scores with several samples in the low range (wider diameters of the black violin) and the DNA fragmentation was statistically significantly higher than in coldFFPE
(gray violin). (C) Dot plot illustrating the Pearson correlation between the QC scores of corresponding samples fixed with the two protocols. The absence of a robust
correlation suggests the reduced influence of the intra-individual fragmentation on the QC score. (D) QC distribution among the sample sets. Violin plots representing
the QC score of the samples, which are grouped according to the fixation methods (stdFFPE and coldFFPE) and the time of collection [Cohort A (collected 6 years
prior to the study with DNA extraction at present time); Cohort B (collected at time of the present study with contextual DNA extraction)]. The QC scores of coldFFPE
samples are comparable between the two cohorts, regardless of time of collection/fixation (p = 0.79), whereas the QC score of stdFPPE samples are significantly
lower in Cohort A compared to Cohort B (p < 0.0001). Notably, the DNA purified from Cohort B samples displayed a better preservation in both stdFFPE and
coldFFPE, nevertheless coldFFPE samples still showed a higher QC distribution. n.s. not significant, *p < 0.05, ***p < 0.001.
carcinoma samples, and these values were significantly lower
compared to all the other samples, either stdFFPE or coldFFPE
(p = 0.0009). By focusing on the same samples treated with cold
formalin, breast specimens confirmed the tissue-specific DNA
degradation, compared with lung and colon cancer tissues (p
= 0.02), more pronounced within the standard fixed samples
(p = 0.0002). By investigating the intrasample QC score ratio
between stdFFPE and coldFFPE, the highest advantage from
cold formalin fixation was observed for DNAs purified from
breast carcinoma specimens, with average 7.7-fold increase in
the long amplicon in the coldFFPE compared to the stdFFPE
samples (Figure 3).
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FIGURE 3 | QC score and QC score fold change in breast, colon, and lung carcinoma samples. The heatmap represents the QC score for purified DNA from stdFFPE
and coldFFPE samples. The histogram shows the fold changes of the QC score in coldFFPE compared to the corresponding stdFFPE samples. The order of the
samples in the heatmap is defined by the color in the histogram. All the breast stdFFPE samples shows the lowest QC score level, which is less heterogenous among
the coldFFPE specimens. Nine of the first ten samples with and increased level of DNA integrity have a mammary site of origin, confirming the specific improvement
for breast cancer tissue.
FIGURE 4 | QC score distribution in the subgroup analysis of the 14 tissue pairs with a second DNA extraction after 6 months from collection/fixation. (A) Violin plots
representing the QC scores in a head to head comparison between DNA extraction at baseline and after 6 months, subdivided by standard fixation (stdFFPE) and
cold fixation (coldFFPE). Significantly lower QC scores are observed after 6 months in stdFFPE samples, whereas comparable QC scores are displayed for coldFFPE
samples. (B) Bubble plot of the QC score for each patient. The plot showed the basal QC score on the Y axes and the 6-month QC score on the X axes, paired for
each sample. The bubble size illustrates the drop in terms of QC score for each couple of DNA samples purified after 6 months of archival. n.s. not significant,
***p < 0.001.
DNA Integrity Following 6 Months of
Storage
Based on the lowest level of DNA integrity observed in
stdFFPE samples of Cohort A and on the better values
of QC scores detected in stdFFPE samples of Cohort B,
we hypothesized that the time of storage could have had
an impact on DNA integrity. In subgroup analysis of the
14 tissue pairs that underwent a second extraction after
6 months from collection and fixation we were able to
perform a head to head comparison of the QC score
values of DNA extracted following FFPE storage of 6
months to those of the DNA extracted at time of collection
(Supplementary Table 2). We observed significantly lower
QC scores for the stdFFPE samples (p < 0.0001; with a mean
percentage loss of 35%) and comparable QC scores for the
coldFFPE samples (p = 0.131, with a mean percentage loss
of 9%) (Figure 4).
DISCUSSION
Our experimental study shows that formalin fixation of tissue
specimens at 4◦C (cold fixation) leads to a better preservation
of DNA as exemplified by the significantly lower levels of
fragmentation in DNA samples obtained from coldFFPE as
compared to those from stdFFPE tissue samples. In addition,
the results in our hands suggest an important impact of time
of storage of FFPE samples on DNA integrity that can be
circumvented by cold fixation. This seems to be particularly
important for breast cancer specimens, which showed the most
detrimental effect with standard fixation overall.
Frontiers in Oncology | www.frontiersin.org 6 February 2020 | Volume 10 | Article 173
Berrino et al. Cold Formalin Preserves DNA Integrity
It is universally acknowledged that optimal DNA quality is
obtained from fresh frozen tissue specimens, which represents
also the backbone of tissue biobanking. Nevertheless, systematic
freezing in pathology laboratories is seldom feasible on a
routine basis, being restricted mainly to research Institutes where
a proper Biobank is in place with dedicated personnel. On
the other side we should take into account that diagnostic
pathology is constantly reshaping due to the contribution of
several molecular assays (including NGS-based approaches) to
the diagnostic process, leading to either a better definition of
the lesion, or a better prognostic and/or predictive stratification
of the disease (precision medicine). For instance, depending
on the site of origin and on the histologic type of a tumoral
lesion genetic alterations such as mutations, translocations and
gene expression signatures are currently being assayed in clinical
practice [reviewed in (11)]. As pointed out by Schillaci et al.
the primary goal of radiological and pathological evaluation
is to increase the quality of life of oncological patients, both
through the reduction and the invasiveness of the methods as
well as by the accuracy of molecular analyses (12). Feasibility,
robustness and reproducibility of molecular assays are therefore
key in this respect and these features are strictly dependent
on the integrity of DNA/RNA, which derives from a proper
management of tissue during the preanalytical phase, including
formalin fixation. Although several molecular assays have been
designed and optimized on FFPE tissue samples and robustness
has been shown, there are important scenarios in which
genomic analyses on DNA extracted from FFPE samples are
challenging. High throughput sequencing methods, such as
Tumor Mutation Burden, somatic detection of BRCA1 and
BRCA2 single nucleotide variants and copy number variations
that can address patient to targeted therapeutic approaches (13),
are strongly influenced by DNA integrity (14, 15). The pilot study
for the 100,000 Genome Project excluded significant number of
samples due to the poor quality of DNA extracted from FFPE
samples, and the enrolled tissues revealed coverage unbalance
after sequencing (16).
Cold formalin fixation has been used in other studies,
mainly focused on RNA integrity. Our group (2) and others
(17) have highlighted a better preservation of RNA molecules,
whereas very little is known in terms of DNA integrity.
Our systematic approach that analyzed the DNA fragment
distribution in paired tissues with different formalin fixation
methods provides direct evidence of a lesser degree of DNA
fragmentation in coldFFPE samples, which showed significantly
higher QC score values compared to stdFFPE DNA samples.
Of note, the degree of statistically significant difference between
coldFFPE and to stdFFPE DNA samples was higher in Cohort
A, composed of specimens collected 6 years prior to the
present study and whose DNA was recovered at time of
the present study, compared to the Cohort B, composed of
samples collected and extracted at present time. It is important
to note that QC scores of the coldFFPE were comparable
between the two cohorts, thus demonstrating consistency in
obtaining high quality DNA from coldFFPE samples, whereas
we observed relatively higher QC scores in stdFFPE DNA
samples belonging to the prospective cohort, which rendered the
difference with coldFFPE samples less evident, even though still
statistically significant.
These data prompted us to assess whether an effect due
to length of FFPE block storage could have contributed to
the difference. This would be particularly relevant, as archival
FFPE tissue blocks are a source of retrospective and prospective
samples for translational research (18, 19) and, if a better
method of preservation is identified, pathology archives may
become an invaluable source of good quality DNA for future
studies. Guyard et al. reported a systematic quantification of
the time-dependent degradation of DNA in FFPE specimens
and they detected a loss of both quantity and quality of DNA
extracted from the same FFPE samples stored over a period
of several years (4). In our study, we ran a subgroup analysis
on 14 samples that underwent a second DNA extraction after
6 months from collection and fixation. We demonstrated a
significant QC score loss in stdFFPE samples compared to
the first extraction, whereas comparable results were obtained
between first and second DNA extraction for coldFFPE samples,
hence strongly suggesting a better preservation of DNA in tissue
specimens fixed in cold formalin. As a possible mechanism
contributing to this phenomenon one could hypothesize that
cold formalin fixation may be able to reduce both the first
enzymatic degradation of DNA by blocking the DNAse activity
(20) and the formalin-dependent crosslinks that lead to DNA
fragmentation (21).
Another important parameter derived from our data relates
to the tissue type. We detected the highest advantage for DNA
integrity in coldFFPE breast cancer specimens, as compared
with coldFFPE specimens derived from colorectal, lung, and
thyroid carcinoma samples. A tissue specificity for the DNA
quantity and quality has been already reported by other
groups. Bonin et al. showed variable yield and quality of
nucleic acid extraction for different tissue (22) and Guyard
et al. (4) reported a reduced DNA integrity in colorectal
cancer FFPE tissues, probably associated with physiological
characteristics, compared with lung, and urothelial tumors.
The fat tissue the mammary gland is composed of may
hamper an efficient formalin fixation, yet our results seem to
suggest that breast cancer specimens may benefit form cold
formalin fixation.
Our study has some limitations, mainly related to the limited
sample size. Even though we were able to validate our results
in two independently collected series of cases, we cannot rule
out the possible association about tissue specificity for the less
represented tumor types here included. Second, we could not
systematically monitor the DNA fragmentation trend in all of the
specimens over time. Nevertheless, the consistent data obtained
in all the 14 sample pairs of the subgroup analysis we were able
to perform strongly supports the contention of a better DNA
preservation in cold fixed samples.
Finally, our analyses were carried out on parallel sampling
of lesions from surgical samples only. We have preliminary
data in our hands (unpublished results) demonstrating that
cold fixation in core biopsies of breast carcinomas results
in optimal morphology and reliable protein detection by
immunohistochemistry-based assays. Further studies are
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warranted to ascertain whether the advantage in terms of DNA
integrity demonstrated for FFPE samples of surgical specimens
is also observed in core biopsy and cytology samples, which
are smaller in size and may undergo a shorter duration of
formalin fixation.
Despite these limitations, the precise quantification of the
degree of DNA fragmentation that we performed with a
normalized evaluation of the QC score revealed a clear benefit
for DNA preservation in samples fixed in cold (4◦C) formalin.
Hence, we here provide a method to limit DNA degradation
that is likely to (i) ensure a better performance of molecular
diagnostic tests, (ii) enable a higher complexity of genomic
analysis on DNA extracted from FFPE samples, (iii) anticipate
a paradigm shift in pathology laboratories with the creation
of FFPE archival samples that may be better preserved over
time and foster therefore a higher accuracy and throughput of
predictive molecular pathology assays, which have the potential
to ultimately impact on the quality of life of breast cancer patients
in the era of precision medicine.
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